References

  1. GLOPERBA® (colchicine) oral solution. Prescribing Information. SCILEX Pharmaceuticals; March 2024.
  2. Robinson PC, Terkeltaub R, Pillinger MH, et al. Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease. Am J Med. 2022;135(1):32-38. doi: 10.1016/j.amjmed.2021.07.025 Epub 2021 Aug 18.
  3. Data on file. SCILEX Pharmaceuticals; March 2024.
  4. FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken). 2020;72(6):744-760. doi: 10.1002/acr.24180 Epub 2020 May 11.
  5. Kim HW, Joo YS, Yun HR, et al. Colchicine use and the risk of CKD progression: a multicentre nested case-control study. Rheumatology (Oxford). 2022;61(11):4314-4323. doi:10.1093/rheumatology/keac077
  6. Khanna D, Khanna PP, FitzGerald JD, et al; American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken). 2012;64(10):1447-1461. doi: 10.1002/acr.21773
  7. Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol. 2004;31(12):2429-2432.
  8. Wason S, Mount D, Faulkner R. Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease. Clin Drug Investig. 2014;34(12):845-855. doi: 10.1007/s40261-014-0238-6
  9. Rahimi M, Alizadeh R, Hassanian-Moghaddam H, Zamani N, Kargar A, Shadnia S. Clinical manifestations and outcomes of colchicine poisoning cases; a cross sectional study. Arch Acad Emerg Med. 2020;8(1):e53. PMID: 32440664
  10. Data on file. SCILEX Pharmaceuticals; March 2024.
  11. Niel E, Scherrmann JM. Colchicine today. Joint Bone Spine. 2006 Dec;73(6):672-678. doi: 10.1016/j.jbspin.2006.03.006.
  12. Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol. 2004;31(12):2429-2432.
  13. Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T. Gastrointestinal tract disorders in older age. Can J Gastroenterol Hepatol. 2019 Jan;2019:6757524. doi: 10.1155/2019/6757524
  14. Fravel MA, Ernst ME. Management of gout in the older adult. Am J Geriatr Pharmacother. 2011;9(5):271-285. doi: 10.1016/j.amjopharm.2011.07.004 Epub 2011 Aug 17.
  15. Niel E, Scherrmann JM. Colchicine today. Joint Bone Spine. 2006 Dec;73(6):672-678. doi: 10.1016/j.jbspin.2006.03.006
  16. Srivastava K, Arora A, Kataria A, Cappelleri JC, Sadosky A, Peterson AM. Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence. 2013 May 20;7:419-434. doi: 10.2147/PPA.S44646
  17. COLCRYS (colchicine, USP) tablets. Prescribing Information. Takeda Pharmaceuticals America, Inc.; November 2012.
  18. Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine: old and new. Am J Med. 2015;128(5):461-470.
  19. Francis-Sedlak M, LaMoreaux B, Padnick-Silver L, Holt RJ, Bello AE. Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study. Rheumatol Ther. 2021 Mar;8(1):183-197. doi: 10.1007/s40744-020-00260-1
  20. Chaudhri K, Kearney M, Di Tanna GL, Day RO, Rodgers A, Atkins ER. Does splitting a tablet obtain the accurate dose?: A systematic review protocol. Medicine (Baltimore). 2019 Oct;98(42):e17189. doi: 10.1097/MD.0000000000017189
  21. GLOPERBA medication guide. SCILEX, LLC; 2019.